focus -WSS

focus

author：comprehensive 2025-09-28 21:07:05 - browse：1

Two people shake hands over a wall with dollar signs floating above their heads. -- health business coverage from STAT — Adobe

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. Congratulations on almost making it to the end of the week! For that, I have a little treat for you at the bottom of the newsletter.

But first, the biotech news of the day.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Beach reads and more: STAT's 2023 summer book list

hotspot

WSS

Why hospitals are withdrawing from US News rankings

Startup Neumora takes a novel depression drug to Phase 3

What to know about OceanGate, the company behind the missing Titanic submersible

A new study sees potential in DNA sequencing of infants

Sanofi seeks simpler, safer CRISPR sickle cell cure

A new study sees potential in DNA sequencing of infants

focus

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Wikipedia

Novavax promises a turnaround & Lilly roils the obesity market

Startup Neumora takes a novel depression drug to Phase 3

In age of alternative facts, a scholarly course on calling out crap

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Hepatitis C has a cure — but many Americans still lack access to it

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

The high cost of giving birth even with insurance

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

Alkermes shareholders re

Sanders adds drug shortage policies to pandemic preparedness bill

Wikipedia

How Medicaid coverage policies for immigrants impact new moms

Iowa House, Senate pass 6

HCA discloses massive data breach affecting 11 million patients

Cosmetics set for new safety regulation. Why the industry is on board

It's time to get medical device identifiers over the finish line

Startup Neumora takes a novel depression drug to Phase 3

focus

focus

hotspot

explore